Valiant Advanced Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 04-11-2024
- Paid Up Capital ₹ 0.19 M
as on 04-11-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 105.70 Cr
as on 04-11-2024
About Valiant Advanced Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 0.19 M.
The company currently has active open charges totaling ₹105.70 Cr.
Santosh Vora, Paresh Shah, Sonal Vira, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2022PTC386388
- Company No.
386388
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2022
- Date of AGM
11 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Valiant Advanced Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Vora  | Director | 08-Jul-2022 | Current |
| Paresh Shah | Director | 08-Jul-2022 | Current |
| Sonal Vira | Additional Director | 19-Apr-2024 | Current |
| Jyotibhushan Singh | Director | 04-Jan-2023 | Current |
Financial Performance and Corporate Structure Insights of Valiant Advanced Sciences.
Valiant Advanced Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Valiant Advanced Sciences?
Unlock access to Valiant Advanced Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Valiant Laboratories LimitedActive 3 years 4 monthsSantosh Vora, Paresh Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 06 Feb 2024 | ₹4.40 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 11 Sep 2023 | ₹1.30 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 Sep 2023 | ₹100.00 Cr | Open |
How Many Employees Work at Valiant Advanced Sciences?
Valiant Advanced Sciences has a workforce of 13 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valiant Advanced Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valiant Advanced Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
